AKT inhibitor
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for AKT inhibitor, covering 2014-12-23 to 2025-11-26. Get the full timeline:
Most recent: Clinical Trial Update: Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer [Phase 1, Phase 2]